Pinnacle Financial Partners Inc Exact Sciences Corp Transaction History
Pinnacle Financial Partners Inc
- $4.82 Billion
- Q1 2025
A detailed history of Pinnacle Financial Partners Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Pinnacle Financial Partners Inc holds 2,710 shares of EXAS stock, worth $144,443. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,710
Previous 2,710
-0.0%
Holding current value
$144,443
Previous $152,000
23.03%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
645Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$951 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$940 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$666 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$643 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$353 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.43B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...